Pfizer Resolves Promosome Patent Lawsuit Over COVID-19 Vaccine
Pfizer, BioNTech and biotech firm Promosome have agreed to end Promosome's lawsuit accusing the COVID-19 vaccine makers of infringing a patent related to messenger RNA technology.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/997111?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/997111?src=rss
Comments
Post a Comment